Allergan Textured Breast Implants Recalled Due to Lymphoma Cancer Concerns
Contact Us Today to Learn How You Can Take Action.
# Allergan Breast Implant Lymphoma Lawsuit
THE FDA HAS RECALLED ALLERGAN TEXTURED BREAST IMPLANTS DUE TO BIA-ALCL RISK.
Yep, you read that right. R-E-C-A-L-L. Even though the FDA ruled earlier this year to keep the implants on the market, that all changed in July 2019 when new data made it clear: Allergan’s BIOCELL breast implants (the kind with the textured surface) have been linked to a disproportionate amount of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) diagnoses. The FDA’s decision follows similar actions taken in France, Australia and Canada.
In the new study, the FDA found a total of 573 cases of BIA-ALCL across the globe, including 33 deaths, a significant increase since the last update in March 2019. Of the 573 reported cases, more than 80% are linked to the Allergan breast implants. The same study also found that the risk of BIA-ALCL was approximately six times higher with Allergan’s textured implants than with other manufacturers’ textured implant products sold in the U.S.
Per the FDA’s request, Allergan is moving forward with a voluntary recall of the company’s BIOCELL textured breast implants products, including:
- Natrelle Saline-Filled breast implants
- Natrelle Silicone-Filled breast implants
- Natrelle Inspira Silicone-Filled breast implants
- Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants
It’s time to step up and say E-N-O-U-G-H! One woman suffering from lymphoma due to breast implants is already too many. Contact us today to learn your legal options if you have or had Allergan breast implants.
ALL YOU WANTED WAS TO FEEL NORMAL AGAIN AFTER CANCER
You aren’t really the implant type, but you just wanted everything to go back to normal after dealing with breast cancer. So, you got the implants. Call it the mark of a cancer survivor. It’s hard to believe these implants – a symbol of you getting your life back – could cause you to get cancer…again. It’s not right.
Even if you have not been diagnosed with BIA-ALCL, you may still have legal options! Contact us to learn more.
“Although the overall incidence of BIA-ALCL appears to be relatively low, once the evidence indicated that a specific manufacturer’s product appeared to be directly linked to significant patient harm, including death, the FDA took action to alert the firm to new evidence indicating a recall is warranted to protect women’s health,”
said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D.